Change: -0.13 %Chge: -2.43% Vol: 199
ALRN Chart
You need Flash Player to see the chart, please download from the link below
Online News For American Learning New Yor
What’s Aileron Therapeutics Inc (NASDAQ:ALRN) Upside After This Short Interest Decrease?
The stock of Aileron Therapeutics Inc (NASDAQ:ALRN) registered a decrease of 5.81% in short interest. ALRN’s total short interest was 188,100 shares in June as published by FINRA. Its down 5.81% from 199,700 shares, reported previously. With 54,400 ...
Preclinical Studies of MDMX and MDM2 Lead to Phase I Trials in Patients With AML
Results of preclinical research conducted on the endogenous inhibitors MDMX and MDM2 has led to the launch of a phase I study involving the targeted agent ALRN-6924. The tumor suppressor p53 is usually inactivated via its interaction with inhibitors MDMX ...
Aileron Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
An archived version of the webcast will be available for replay following the event. ALRN-6924 is a first-in-class product candidate designed to reactivate wild type p53 tumor suppression by disrupting the interactions between p53 and the two primary p53 ...
An Integrated BioSci Rounds Report: Atara Rallied While Stellar FDA Due Diligence To Unlock Value For Innovators
As featured in table 1, the interesting transactions came from Aileron Therapeutics (ALRN). On June 08, 2018, Manuel Alvado purchased 1.0K shares for $5.6K. Back on June 01, the SVP and CFO Donald Dougherty also bought 2.0K shares for $10.4K. Despite the ...
Want To Add This Quote To Your Site?
With our stock widgets you can add a American Learning New Yor quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for ALRN to choose from. Visit here to build your stock quote widget »
